Einav Vax
Impact in
- Hepatology top 10%
-
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
Papers in
-
- Renal and related cancers 7
- Epigenetics and DNA Methylation 1
- Pluripotent Stem Cells Research 1
-
- Renal cell carcinoma treatment 4
- Co-authors
- Ron N. Apte (2 shared papers)Charles A. Dinarello (2 shared papers)Yehuda Kamari (2 shared papers)Dror Harats (2 shared papers)Shai Shemesh (2 shared papers)Shahar Dotan (2 shared papers)Aviv Shaish (2 shared papers)Iris Barshack (5 shared papers)
- Journals
- Stem Cell Reports (2 papers)PLoS ONE (1 paper)Molecular Cancer Therapeutics (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- IsraelUnited States
In The Last Decade
Einav Vax
13 papers receiving 596 citations
Peers
Comparison fields: 5 of 66
- Hepatology 54
- Epidemiology 188
- Immunology 112
- Molecular Biology 291
- Cell Biology 54
Countries citing papers authored by Einav Vax
This map shows the geographic impact of Einav Vax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Einav Vax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Einav Vax more than expected).
Fields of papers citing papers by Einav Vax
This network shows the impact of papers produced by Einav Vax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Einav Vax. The network helps show where Einav Vax may publish in the future.
Co-authors
The 25 scholars most cited alongside Einav Vax, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 255 | |
| 2 | 2011 | 86 | |
| 3 | 2013 | 52 | |
| 4 | 2016 | 43 | |
| 5 | 2014 | 38 | |
| 6 | 2018 | 25 | |
| 7 | 2016 | 25 | |
| 8 | 2017 | 23 | |
| 9 | 2014 | 22 | |
| 10 | 2017 | 21 | |
| 11 | 2019 | 7 | |
| 12 | 2025 | 3 | |
| 13 | 2020 | 1 |
About Einav Vax
Einav Vax is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Immunology, having authored 13 papers that have together received 601 indexed citations. Recurring topics across this work include Renal and related cancers (7 papers), Renal cell carcinoma treatment (4 papers), Epigenetics and DNA Methylation (1 paper), NF-κB Signaling Pathways (1 paper), Pluripotent Stem Cells Research (1 paper), Renal Diseases and Glomerulopathies (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper) and Viral Infections and Immunology Research (1 paper). The work is most often cited by research in Hepatology (54 citations), Epidemiology (188 citations), Immunology (112 citations), Molecular Biology (291 citations) and Cell Biology (54 citations). Einav Vax has collaborated with scholars based in Israel and United States. Frequent co-authors include Ron N. Apte, Charles A. Dinarello, Yehuda Kamari, Dror Harats, Shai Shemesh, Shahar Dotan, Aviv Shaish, Iris Barshack, Yaron Arbel and Michal Kandel-Kfir. Their work appears in journals such as Stem Cell Reports, PLoS ONE, Molecular Cancer Therapeutics, Frontiers in Bioengineering and Biotechnology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.